BRIEF-Active Biotech Q2 loss narrows, Anyara project activities on hold
Aug 7 (Reuters) - Active Biotech : * Says net sales 2.7 million crowns April-June (2.5 mln Q2 2013) * Q2 - operating loss -57.9 million sek (versus -79.5 Q2 2013) * Says will not commence the further clinical development of Anyara on an
independent basis and will only proceed together with a partner * Says all Anyara project activities will be put on hold until further notice * Says development program for further clinical development of Anyara outlined
in collaboration with regulatory authorities Link to full report: here
DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.